Cardiovascular response to intravenous administration of 5-hydroxytryptamine after type-2 receptor blockade, by metrenperone, in healthy calves

Veterinary Journal

Volumn 157, Issue 1, 1999, Pages 31-37

  Linden, A ^a   Desmecht, D ^a   Amory, H ^a   Lekeux, P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Cattle; Serotonin

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; METRENPERONE; SEROTONIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APNEA; ARTERIAL PRESSURE; ARTICLE; BRADYCARDIA; CARDIOVASCULAR RESPONSE; CATTLE; CHRONOTROPISM; CONTROLLED STUDY; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HYPERTENSION; HYPOTENSION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; NONHUMAN; PULMONARY HYPERTENSION; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA;

ANIMALIA; BOS TAURUS; FRIESIA;

EID: 0033010015     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1053/tvjl.1998.0250     Document Type: Article

References (30)

1. AMORY, H., LINDEN, A., DESMECHT, D., ROLLIN, F., GENICOT, B. & LEKEUX, P. (1991). Validation of the thermodilution technique for the estimation of the cardiac output in the unsedated calf. Journal of Veterinary Medicine A 38, 409-17.
2. APPERLEY, E., FENIUK, W., HUMPHREY, P. P. A. & LEVY, G. P. (1980). Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. British Journal of Pharmacology 68, 215-24.
3. BLACK, J. L., FRENCH, R. J. & MYLECHARANE, E. J. (1981). Receptor mechanisms for 5-hydroxytryptamine in rabbit arteries. British Journal of Pharmacology 74, 619-26.
4. 1A-receptors play a role in the von Bezold-Jarisch reflex in the rat. British Journal of Pharmacology 100, 757-60.
5. 2 type, mediating contraction of isolated rabbit basilar artery. British Journal of Pharmacology 87, 3-4.
6. DAROVIC, G. O. (1987). Hemodynamic Monitoring. Invasive and Noninvasive Clinical Application, ed. D. Kay, Philadelphia: WB Saunders Company.
7. EI-FAWAL, H. A. N., OGUNBIYI, P. O., GORDON, V. & EYRE, P. (1985). Reactivity of the bronchial artery to 5-hydroxytryptamine. Research Communications in Chemical Pathology and Pharmacology 50, 325-36.
8. FENIUK, W., HARE, J. & HUMPHREY, P. P. A. (1981). Analysis of the mechanism of 5-hydroxytryptamine-induced vasopressor responses in ganglion-blocked anaesthetized dogs. Journal of Pharmacy and Pharmacology 33, 155-60.
9. FOZARD, J. R. (1984). MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 326, 36-44.
10. 2 receptors in pulmonary and coronary arteries of calf. Naunyn-Schmiedeberg's Archives of Pharmacology 326, 334-9.
11. HOYER, D., CLARKE, D. E., FOZARD, J. R., et al. (1994). International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacological Reviews 46, 157-98.
12. 2 receptor blockade to study serotonin-induced pathology. Tips Reviews May, 198-206.
13. 1 receptors. European Journal of Pharmacology 91, 155-6.
14. 2 receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 323, 149-54.
15. LANGER, S. Z. (1981). Presynaptic regulation of the release of catecholamines. Pharmacological Review 32, 337-62.
16. LINDEN, A. S., DESMECHT, D. J.-M., AMORY, H., BEDUIN, J. -M. & LEKEUX, P. M. (1996). Cardiovascular response to exogenous serotonin in healthy calves. American Journal of Veterinary Research 57, 731-8.
17. MELLER, S. T., LEWIS, S. J., BRODY, M. J. & GEBHART, G. F. (1992). Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes. Brain Research 585, 71-86.
18. OGUNBIYI, P. O. & EYRE, P. (1984). Effects of tryptamine antagonists on the anaphylactic contractions of the bovine pulmonary smooth muscles. Journal of Veterinary Pharmacology and Therapeutics 7, 153-8.
19. OOMS, L. A. A. & VERHEYEN, A. K. (1982). Malignant hyperthermia: etiology, pathophysiology and prevention. In: 5-Hydroxytryptamine in Peripheral Reactions, eds F. De Clerck & P. M. Vanhoutte, pp. 129-39, New York: Raven Press.
20. 1a receptors. Journal of Pharmacology and Experimental Therapeutics 237, 901-6.
21. SAXENA, P. R. (1986). Nature of the 5-hydroxytryptamine receptors in mammalian heart. Progress in Pharmacology 6, 173-85.
22. SAXENA, P. R. (1989). Cardiovascular effects from stimulation of 5-hydroxytryptamine receptors. Fundamental & Clinical Pharmacology 3, 245-65.
23. 1 receptors. Archives Internationales de Pharmacodynamie 277, 235-52.
24. 1 binding sites, dilates arterioles and constricts arteriovenous anastomoses. British Journal of Pharmacology 84, 533-44.
25. 1-like receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 330, 121-9.
26. SERTEYN, D., OOMS, L., DEGRYSE, A., COPPENS, P., , MOTTART, E. & PHILIPPART, C. (1989). Effects cardiovasculaires du R50970, une substance antisérotonine, chez le cheval anesthésié à l'halothane. Annales de Médecine Vétérinaire 133, 505-14.
27. VAN DE PUTTE-VAN MESSOM, G. & BURVENICH, C. (1991). The effect of ketanserin on the 5-HT-induced pressor response in the isolated bovine pulmonary artery. Archives Internationales de Physiologie, de Biochemie et de Biophysique 99, P23.
28. VANHOUTTE, P. M., BALL, S. G., BERDEAUX, A. et al. (1986). Mechanism of action of ketanserin in hypertension. Trends Pharmacol Sci. 7, 58-9.
29. VAN NUETEN, J. M., LEYSEN, J. E., VANHOUTTE, P. M. & JANSSENS, P., A. J. (1982a). Serotonergic responses in vascular and non-vascular tissues. Archives Internationales de Pharmacodynamie et de Thérapie 256, 331-4.
30. VAN NUETEN, J. M., JANSSEN, P. A. J., DE RIDDER, W. & VANHOUTTE, P. M. (1982b). Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit: effect of ketanserin (R41468). European Journal of Pharmacology 77, 281-7.